BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Head and neck cancer AND FGFR1, CEK, 2260, ENSG00000077782, P11362, FLT2, CD331, H3, HBGFR, FGFBR, H5, KAL2, H2, BFGFR, N-SAM, H4 AND Prognosis
98 results:

  • 1. Epigenetics in the diagnosis and prognosis of head and neck cancer: A systematic review.
    Lim I; Tan J; Alam A; Idrees M; Brenan PA; Coletta RD; Kujan O
    J Oral Pathol Med; 2024 Feb; 53(2):90-106. PubMed ID: 38316046
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Analysis of B7-H4 Expression Across Salivary Gland Carcinomas Reveals Adenoid Cystic Carcinoma-Specific Prognostic Relevance.
    Siqueira JM; Mitani Y; Hoff CO; Bonini F; Guimaraes de Sousa L; Marques-Piubelli ML; Purushothaman A; Mitani M; Dai H; Lin SY; Spiotto MT; Hanna EY; McGrail DJ; El-Naggar AK; Ferrarotto R
    Mod Pathol; 2024 Jan; 37(1):100371. PubMed ID: 38015043
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. B7H3 targeting gold nanocage pH-sensitive conjugates for precise and synergistic chemo-photothermal therapy against NSCLC.
    Chen B; Zheng K; Fang S; Huang K; Chu C; Zhuang J; Lin J; Li S; Yao H; Liu A; Liu G; Lin J; Lin X
    J Nanobiotechnology; 2023 Oct; 21(1):378. PubMed ID: 37848956
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Prognostic analysis and treatment utilization of different treatment strategies in elderly esophageal cancer patients with distant metastases: a SEER database analysis.
    Han LQ; Cui TT; Xiao NJ; Li W
    J Cancer Res Clin Oncol; 2023 Nov; 149(17):15413-15423. PubMed ID: 37644234
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. THSD7A Positivity Predicts Poor Survival and Is Linked to High FAK Expression and fgfr1-Wildtype in Female Patients with Squamous Cell Carcinoma of the Lung.
    Flockerzi FA; Hohneck J; Langer F; Bohle RM; Stahl PR
    Int J Mol Sci; 2023 Jun; 24(13):. PubMed ID: 37445817
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Nomogram for preoperative estimation risk of lateral cervical lymph node metastasis in papillary thyroid carcinoma: a multicenter study.
    Zhu J; Chang L; Li D; Yue B; Wei X; Li D; Wei X
    Cancer Imaging; 2023 Jun; 23(1):55. PubMed ID: 37264400
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Spatial Immunoprofiling of Adenoid Cystic Carcinoma Reveals B7-H4 Is a Therapeutic Target for Aggressive Tumors.
    Sousa LG; McGrail DJ; Lazar Neto F; Li K; Marques-Piubelli ML; Ferri-Borgogno S; Dai H; Mitani Y; Spardy Burr N; Cooper ZA; Kinneer K; Cortez MA; Lin SY; Bell D; El Naggar A; Burks J; Ferrarotto R
    Clin Cancer Res; 2023 Aug; 29(16):3162-3171. PubMed ID: 37256648
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Histone lysine methyltransferase SMYD3 promotes oral squamous cell carcinoma tumorigenesis via H3K4me3-mediated HMGA2 transcription.
    Yang Z; Liu F; Li Z; Liu N; Yao X; Zhou Y; Zhang L; Jiang P; Liu H; Kong L; Lang C; Xu X; Jia J; Nakajima T; Gu W; Zheng L; Zhang Z
    Clin Epigenetics; 2023 May; 15(1):92. PubMed ID: 37237385
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Anti‑tumor properties of FoxO1 in YD‑9 oral squamous cell carcinoma cells.
    Kim YG; Seong C; Cho KA; Lee SM; Kim TJ; Kim HJ; Cho JH; Jung W; Jang S; Shin JC; Lee KH; Byun JS; Kim DY
    Oncol Rep; 2023 Jun; 49(6):. PubMed ID: 37144504
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. STC2 activates PRMT5 to induce radioresistance through DNA damage repair and ferroptosis pathways in esophageal squamous cell carcinoma.
    Jiang K; Yin X; Zhang Q; Yin J; Tang Q; Xu M; Wu L; Shen Y; Zhou Z; Yu H; Yan S
    Redox Biol; 2023 Apr; 60():102626. PubMed ID: 36764215
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Evaluation of serum B7-H3 expression, ultrasound and clinical characteristics to predict the risk of cervical lymph node metastases in papillary thyroid carcinoma by nomogram.
    Huang Y; Huang Z; Cai H; Zhuge L; Wang S; Yan D; Zhang X; An C; Niu L; Li Z
    J Clin Lab Anal; 2023 Jan; 37(1):e24811. PubMed ID: 36525343
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Genome-Wide Super-Enhancer-Based Analysis: Identification of Prognostic Genes in Oral Squamous Cell Carcinoma.
    Saito T; Asai S; Tanaka N; Nohata N; Minemura C; Koma A; Kikkawa N; Kasamatsu A; Hanazawa T; Uzawa K; Seki N
    Int J Mol Sci; 2022 Aug; 23(16):. PubMed ID: 36012427
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Inhibition of DNMT1 potentiates antitumor immunity in oral squamous cell carcinoma.
    Yang SC; Wang WY; Zhou JJ; Wu L; Zhang MJ; Yang QC; Deng WW; Sun ZJ
    Int Immunopharmacol; 2022 Oct; 111():109113. PubMed ID: 35944462
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. The prognostic impact of B7-H3 and B7-H4 in head and neck squamous cell carcinoma.
    Borgmann M; Oetting A; Meyer F; Möckelmann N; Droste C; von Bargen CM; Möller-Koop C; Witt M; Borgmann K; Rothkamm K; Betz C; Münscher A; Clauditz TS; Rieckmann T
    J Cancer Res Clin Oncol; 2023 Jul; 149(7):3383-3393. PubMed ID: 35941227
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Immune Checkpoint Protein Expression Defines the prognosis of Advanced Thyroid Carcinoma.
    Luo Y; Yang YC; Shen CK; Ma B; Xu WB; Wang QF; Zhang Y; Liao T; Wei WJ; Wang Y
    Front Endocrinol (Lausanne); 2022; 13():859013. PubMed ID: 35574031
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Combining structure-based and 3D QSAR pharmacophore models to discover diverse ligands against EGFR in oral cancer.
    Chakraborty P; Ahil SB; Jamma T; Yogeeswari P
    Future Med Chem; 2022 Apr; 14(7):463-478. PubMed ID: 35167330
    [No Abstract]    [Full Text] [Related]  

  • 17. LINC01123 promotes immune escape by sponging miR-214-3p to regulate B7-H3 in head and neck squamous-cell carcinoma.
    Li H; Yang Z; Yang X; Zhang F; Wang J; Wu Z; Wanyan C; Meng Q; Gao W; Yang X; Wei J
    Cell Death Dis; 2022 Feb; 13(2):109. PubMed ID: 35115487
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Immunomodulation via FGFR inhibition augments fgfr1 targeting T-cell based antitumor immunotherapy for head and neck squamous cell carcinoma.
    Kono M; Komatsuda H; Yamaki H; Kumai T; Hayashi R; Wakisaka R; Nagato T; Ohkuri T; Kosaka A; Ohara K; Kishibe K; Takahara M; Katada A; Hayashi T; Kobayashi H; Harabuchi Y
    Oncoimmunology; 2022; 11(1):2021619. PubMed ID: 35003900
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. The prognostic and clinical significance of IFI44L aberrant downregulation in patients with oral squamous cell carcinoma.
    Ou D; Wu Y
    BMC Cancer; 2021 Dec; 21(1):1327. PubMed ID: 34903206
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Multi-Omics Data Analyses Identify B7-H3 as a Novel Prognostic Biomarker and Predict Response to Immune Checkpoint Blockade in head and neck Squamous Cell Carcinoma.
    Lin W; Xu Y; Gao J; Zhang H; Sun Y; Qiu X; Huang Q; Kong L; Lu JJ
    Front Immunol; 2021; 12():757047. PubMed ID: 34675936
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 5.